Admin

After investing $18.5 billion in a partnership with CSPC Pharmaceutical Group, AstraZeneca's earnings per share are expected to increase by double digits.

After investing $18.5 billion in a partnership with CSPC Pharmaceutical Group, AstraZeneca's earnings per share are expected to increase by double digits.

On February 10, AstraZeneca projected that its adjusted earnings per share will achieve double-digit percentage growth in 2026, in line with market expectations. The company stated that the strong sales momentum of its oncology drug business will effectively offset the impact of patent expirations in its core diabetes drug portfolio,
Admin
Evaluation surpasses Google and Nvidia! Alibaba releases RynnBrain robot model: enabling robots to possess a "thinking brain"

Evaluation surpasses Google and Nvidia! Alibaba releases RynnBrain robot model: enabling robots to possess a "thinking brain"

``` On February 10, Alibaba officially launched the RynnBrain foundational AI model for robotics. This open-source model aims to endow robots with perception, decision-making, and execution abilities, driving autonomous task completion in real-world scenarios. RynnBrain is independently developed by Alibaba DAMO Academy and possesses core capabilities such as environmental interaction, spatiotemporal